– USA, RI – Spectra Systems Corporation (LON: SPSY), a leader in machine-readable high-speed banknote authentication, brand protection technologies, and gaming security software, today announced the appointment of Dr. Barbara Paldus (Ph.D.) to its Board as an Independent Non-Executive Director.
“I am delighted to welcome Barbara to Spectra Systems and believe that her extensive entrepreneurial experience, particularly in technology solutions will be of immense value to us.” said CEO, Dr. Nabil Lawandy.
About Dr. Barbara Paldus
Dr. Barbara Paldus has over 20 years of industry expertise in developing emerging domestic and international marketplaces, including bio-processing, personalized medicine, cell therapy, biotech beauty, and analytical process equipment. She founded two companies whose combined revenue exceeded $250M in 2021. She also has a doctorate in electrical and electronics engineering from Stanford University.
In 1998, Dr. Paldus was the founder of Picarro, a leading provider of cavity-ring-down instruments and solutions to measure greenhouse gas concentrations, trace gases, and stable isotopes across many scientific applications, along with the energy, life science, and utility markets where she successfully exited in 2006. In 2005 she founded Finess Solutions, a leader in developing scalable control automation systems and software for bioproduction. Its Smart proprietary technology, which consists of sensors, controllers, and software is designed to optimize the bioproduction workflow. Finess Solutions was sold to Thermo Fisher in 2017. Barbara was also an operating partner for Skymoon Ventures from 2005 until 2017, a venture fund ($100 million invested) focused on an early-stage chip, GPS, bioproduction, optical laser components, and analytical instrumentation.
Barbara is currently the CEO and Founder of Codex Labs, a Global collection of biotech-based skincare solutions based on disruptive plant-based biotech ingredients, cGMP manufacturing, industry-leading carbon footprint minimizing packaging, and data-driven clinical testing.
For more information: https://www.spsy.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.